The World's Greatest Investing Community
Results 1 - 10 of 516 : 1 2 3 4 5 6 7 8 9 Next
Has Amgen Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
Which Big Biotech Is the Best Bet?
That might depend on which kind of investor you are.
Celgene Meets on the Top Line, Misses Where It Counts
Just the facts, Fool.
2 Biotech Acquisitions in 1 Day! Let's Throw a Party
Amgen and Celgene pull the trigger. Don't drop the keg.
Stocks That Are Raising the Bar
A bullish market signal and positive CAPS sentiment might make a winning combination.
This mechanical strategy could be magic.
Let's find out.
What to Look For With Seattle Genetics in 2012
The launch of its new drug Adcetris will be key.
Is 2012 Make or Break for Cell Therapeutics?
The biotech that wouldn't die.
How Does Pfizer Boost Its Returns?
Break it down with the DuPont formula.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK